Drug
Baloxavir clinical trials
Also written Xofluza and S-033188.
- studies test it
- 20
- open now
- 8
- in phase 3
- 14
- first study started
- 2016
Keep track of what changes. Save the baloxavir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Combined with it in one product
Studies by the year they started
20 studies that test it; most in 2019 (5)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 14
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 10
Hoffmann-La Roche (8) · Shionogi (2) · University of Oxford (2) · Bassett Healthcare (1) · Children's Hospital of Philadelphia (1) · University of Washington (1) · Capital Medical University (1) · Unity Health Toronto (1)
Often tested with
Tested in the same studies.
Oseltamivir (3) · Hydroxychloroquine (2) · Tocilizumab (2) · Aspirin (2) · Baricitinib (2) · Interleukin 1 Receptor Antagonist Protein (2) · Molnupiravir (2) · Nirmatrelvir and ritonavir drug combination (2)
Studies
Open first, then newest update. How each study uses baloxavir is read from its arms, and is right about nine times in ten.
Testing it · 20
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsRecruitingPhase 3Hoffmann-La RocheNCT06094010Written as Baloxavir Marboxil
- A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese ParticipantsRecruitingPhase 3Hoffmann-La RocheNCT07827599Written as Baloxavir marboxil
- Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)RecruitingPhase 3Unity Health TorontoNCT07314905Written as Baloxavir
- Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)RecruitingPhase 3Dre Pauline VetterNCT06653569Written as Baloxavir Marboxil
- Randomised Evaluation of COVID-19 TherapyRecruitingPhase 3University of OxfordNCT04381936Written as Baloxavir Marboxil
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as Baloxavir
- Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based SettingNot yet recruitingNot applicableCapital Medical UniversityNCT06762587Written as Baloxavir Marboxil
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingPhase 3UMC UtrechtNCT02735707Written as Baloxavir Marboxil
- COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)CompletedPhase 2/3Bassett HealthcareNCT04327791Written as Baloxavir
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsCompletedPhase 3Hoffmann-La RocheNCT06774859Written as Baloxavir Marboxil
- Xofluza-Wearables Feasibility-StudyCompletedPhase 4Children's Hospital of PhiladelphiaNCT06161454Written as Baloxavir Marboxil
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsCompletedPhase 3Hoffmann-La RocheNCT03969212Written as Baloxavir Marboxil
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like SymptomsCompletedPhase 3Hoffmann-La RocheNCT03653364Written as Baloxavir Marboxil
- Baloxavir Versus Oseltamivir for Nursing Home Influenza OutbreaksStatus unknownPhase 4Insight Therapeutics, LLCNCT05012189Written as Baloxavir
- Pilot of Cohort of Households for Influenza Monitoring and Evaluation in SeattleCompletedPhase 4University of WashingtonNCT04141930Written as Baloxavir Marboxil
- Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaCompletedPhase 3Hoffmann-La RocheNCT03684044Written as Baloxavir Marboxil
- Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese ParticipantsCompletedNot applicableHoffmann-La RocheNCT03959332Written as Baloxavir Marboxil
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsCompletedPhase 3Hoffmann-La RocheNCT03629184Written as Baloxavir Marboxil
- Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza ComplicationsCompletedPhase 3ShionogiNCT02949011Written as Baloxavir Marboxil
- A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With InfluenzaCompletedPhase 3ShionogiNCT02954354Written as Baloxavir Marboxil
Given in every arm · 1 — baloxavir is usual care beside what is tested
As the comparator · 3 — what is tested is compared with baloxavir
- A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza ARecruitingNot applicableCapital Medical UniversityNCT06205641Written as Baloxavir Marboxil Tablet
- Safety and Efficacy of ADC189 in Children 2-11 Years Old With InfluenzaCompletedPhase 3Jiaxing AnDiCon Biotech Co.,LtdNCT06507813Written as Baloxavir Marboxil tablets
- Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With InfluenzaTerminatedPhase 2/3Weill Medical College of Cornell UniversityNCT05170009Written as Baloxavir Marboxil
Codes
What other systems call baloxavir · ClinicalTrials.gg INT000987
- MeSH (NLM) C000628402baloxavirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4G86Y4JT3FBALOXAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 2197842One source FDA
- Wikidata Q57742876baloxavirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166756BaloxavirOne source FDA
- DrugBank DB15675One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000628402 | baloxavir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4G86Y4JT3F | BALOXAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2197842 | — | One source FDA |
| Wikidata | Q57742876 | baloxavir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166756 | Baloxavir | One source FDA |
| DrugBank | DB15675 | — | One source Wikidata |
Also registered as baloxavir marboxil (UNII 505CXM6OHG · RxNorm 2099995).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.